Topic · page 17 of 21

Prevention & lipids

Lipids, Lp(a), lifestyle (activity, diet, alcohol, smoking), risk scores, primary prevention in general or older populations, frailty and CV risk

Briefs 641–680 of 838 placed here, newest publication first

Briefs in Prevention & lipids

Newest publication first

J Am Coll Cardiol14 May 2024
Long-Term Cardiovascular Risk Associated With Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
Cohort study
JAMA14 May 2024
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a)): A Randomized Clinical Trial
Randomised controlled trial
Eur J Prev Cardiol9 May 2024
Psychometric validation of the short version of the Information Needs in Cardiac Rehabilitation scale through a first global assessment
Cross-sectional study
Nat Med8 May 2024
Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial
Randomised controlled trial
Eur Heart J3 May 2024
Discordance among apoB, non–high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention
Cohort study
Eur J Prev Cardiol23 Apr 2024
Coronary artery calcification and high-volume physical activity: role of lower intensity vs. longer duration of exercise
Cross-sectional study
J Am Coll Cardiol23 Apr 2024
Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical Activity
Cohort study
Nat Med18 Apr 2024
Development and validation of a new algorithm for improved cardiovascular risk prediction
Diagnostic or prognostic study
Eur J Prev Cardiol18 Apr 2024
Current treatments for the management of homozygous familial hypercholesterolaemia: a systematic review and commentary
Meta-analysis
Eur J Prev Cardiol15 Apr 2024
Cardiovascular mortality attributable to dietary risk factors in 54 countries in the WHO European Region from 1990 to 2019: an updated systematic analysis of the Global Burden of Disease Study
Research article
Eur J Prev Cardiol9 Apr 2024
Global burden of cardiovascular disease attributable to smoking, 1990–2019: an analysis of the 2019 Global Burden of Disease Study
Secondary analysis
JACC Cardiovasc Interv8 Apr 2024
Chronological vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series
Research article
J Am Coll Cardiol7 Apr 2024
Prevalence of Cardiovascular Disease and Risk Factors Among Former National Football League Players
Cross-sectional study
J Am Coll Cardiol7 Apr 2024
An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease
Randomised controlled trial
N Engl J Med7 Apr 2024
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
Randomised controlled trial
N Engl J Med7 Apr 2024
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
Randomised controlled trial
Circulation7 Apr 2024
Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial
Randomised controlled trial
JAMA Cardiol1 Apr 2024
Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations
Cohort study
JAMA Cardiol1 Apr 2024
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia
Cohort study
Eur Heart J29 Mar 2024
Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease
Cohort study
Eur J Prev Cardiol28 Mar 2024
Large-scale plasma proteomics in the UK Biobank modestly improves prediction of major cardiovascular events in a population without previous cardiovascular disease
Diagnostic or prognostic study
Nat Med26 Mar 2024
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease
Meta-analysis
J Am Coll Cardiol25 Mar 2024
Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl
Secondary analysis
Eur J Prev Cardiol21 Mar 2024
Non-HDL cholesterol and residual cardiovascular risk in statin-treated patients with and without diabetes: the Western Denmark Heart Registry
Cohort study
Eur J Prev Cardiol14 Mar 2024
Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial
Secondary analysis
JACC Cardiovasc Imaging6 Mar 2024
AI-Defined Cardiac Anatomy Improves Risk Stratification of Hybrid Perfusion Imaging
Cohort study
J Am Coll Cardiol5 Mar 2024
Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease
Cohort study
Eur J Prev Cardiol4 Mar 2024
Sex-specific and polygenic effects underlying resting heart rate and associated risk of cardiovascular disease
Meta-analysis
JAMA Cardiol1 Mar 2024
Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol
Cohort study
JAMA Cardiol1 Mar 2024
Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial
Secondary analysis
Eur J Prev Cardiol28 Feb 2024
Association of apolipoprotein levels with all-cause and cardiovascular mortality
Meta-analysis
J Am Coll Cardiol27 Feb 2024
Sex Differences in Association of Physical Activity With All-Cause and Cardiovascular Mortality
Cohort study
Eur J Prev Cardiol26 Feb 2024
Combination of low- or moderate-intensity statin and ezetimibe vs. high-intensity statin monotherapy on primary prevention of cardiovascular disease and all-cause death: a propensity-matched nationwide cohort study
Cohort study
JACC Cardiovasc Imaging21 Feb 2024
Left Main Coronary Artery Calcium and Diabetes Confer Very-High-Risk Equivalence in Coronary Artery Calcium >1,000
Cohort study
BMJ21 Feb 2024
Exposure-response associations between chronic exposure to fine particulate matter and risks of hospital admission for major cardiovascular diseases: population based cohort study
Cohort study
Eur J Prev Cardiol20 Feb 2024
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry
Cohort study
Eur J Prev Cardiol19 Feb 2024
Risk and incidence of cardiovascular disease associated with polycystic ovary syndrome
Meta-analysis
Eur J Prev Cardiol15 Feb 2024
Physical activity and physical fitness in prediction of all-cause mortality and age at death in European extinct cohorts of middle-aged men followed for 60 years
Cohort study
Eur J Prev Cardiol14 Feb 2024
Cardiovascular benefit of statin use against air pollutant exposure in older adults
Cohort study
Eur J Prev Cardiol13 Feb 2024
Impact of clonal haematopoiesis on atherosclerotic cardiovascular disease according to low-density lipoprotein cholesterol levels in general population
Cohort study

All 838 Briefs in ExploreShowing Briefs 641–680 of 838, newest first